🔗 Share this article

Acclaimed soul vocalist D’Angelo died on the fourteenth of October at age 51 after a personal fight with pancreatic malignancy.

“The shining star of our household has faded away for us in this life,” his relatives confirmed. “After a prolonged and courageous struggle with cancer, we are heartbroken to declare that D’Angelo, known to his fans around the world as D’Angelo, has been taken from us.”

D’Angelo made a lasting impact on the music industry with his innovative modern soul style and collaborations with high-profile artists.

He launched his first record, “Brown Sugar,” in 1995 to instant praise. The record achieved No. 4 on the R&B charts, went platinum later that year, and received several award nominations.

However, it was his sophomore release, “Voodoo,” in 2000 that boosted his music career into the stratosphere. The album debuted at the top spot on each of Billboard’s Top R&B Albums chart and the Billboard 200. He received two Grammys: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a sex symbol, albeit a reluctant one, in the cultural zeitgeist. The intimate portrayal featured the singer, famously stripped down to his midsection, performing straight into the lens.

D’Angelo retreated from the public eye after releasing Voodoo and openly battled with substance abuse. In 2005, he was involved in a severe vehicle accident that left him in critical condition.

Over ten years later, his third and final album, “Black Messiah” (2014), confirmed his enduring appeal with a further No. 1 debut on the R&B chart and a Grammy for Top R&B Record.

Again, in his own enigmatic fashion, D’Angelo made only a few public outings in the subsequent period.

The singer was scheduled as a headliner for the 2025 music event, but his appearance was called off, citing an “unforeseen medical delay.”

Even though details are sparse about D’Angelo’s well-being in the weeks leading up to his passing, he had apparently been in the hospital for an extended period and in palliative care for a fortnight.

D’Angelo’s demise is a stark reminder of the harmful impact of pancreatic cancer, one of the deadliest and least preventable forms of the illness, on a gifted artist whose life was ended too soon.

“We are saddened that he can only provide dear memories with his family, but we are eternally grateful for the legacy of extraordinarily moving music he has left us,” his kin expressed.

Pancreatic Cancer: Deadly and Difficult to Avoid

Pancreatic cancer impacts the pancreas, a tiny gland that generates the hormone insulin and is vital in breaking down food, among other functions. The size and location of the pancreas in the body make it more difficult to identify malignancy.

Although this cancer makes up only about 3% of malignancy cases annually in the United States, it is responsible for seven percent of malignancy fatalities.

Nearly seventy thousand individuals will be diagnosed with this condition and roughly 52,000 will succumb to the disease in the year 2025.

“Pancreatic cancer is one of the deadliest cancers, with an aggressive tumor and poor prognosis. We have few and ineffective therapies, and a narrow opportunity to make a meaningful impact on the well-being of people,” noted a cancer specialist.

Because pancreatic cancer rarely causes early symptoms, it’s often diagnosed only once the condition is advanced. Although a patient has symptoms they are often vague and may be mistaken for a number of common illnesses.

“As of yet, there is no good way to identify this malignancy in the early stages, apart from listening to your body and speaking with your doctor if there are unfamiliar symptoms,” explained a medical director.

Common symptoms of pancreatic cancer include:

• abdominal or lower back pain
• reduced body mass
• jaundice
• reduced hunger
• brownish urine
• pale or fatty bowel movements
• loose stools
• increased appetite or thirst
• nausea

At 51 years old, D’Angelo’s death is an outlier, as this malignancy is most common in individuals in the 65 to 75 age bracket. However, many cancers, such as this type, have become more common in younger adults.

“This disease diagnosed before the age of 50 is deemed rare, yet concerningly, doctors are noticing a rising count of younger patients affected by this condition,” commented a expert.

Genetic Background Affects Disease Probability

Without effective screening tools for this malignancy, experts emphasized the significance of understanding your family’s cancer history. Certain risk factors, such as tobacco use and excess weight also play a role in the onset of pancreatic cancer.

Black individuals have the highest incidence of pancreatic cancer in the U.S. and are more prone to be found to have untreatable disease.

“The first step toward reducing one’s risk of this condition is understanding personal risk factors. Individuals should review their family history, genetic background, and health issues, such as blood sugar disease, long-term pancreas inflammation, or obesity that may raise their susceptibility,” said a medical professional.

Inherited genetic risk factors are associated with as much as ten percent of all pancreatic cancer instances. If a relative in your household has had this disease, you may want to consider genetic testing.

“For people with a family history of pancreatic cancer or those having high risk genetic mutations, screening may involve advanced imaging such as MRI scans or internal ultrasound to detect initial alterations in the pancreas,” he explained.

For those looking to reduce their risk, habit adjustments may make a difference. The best step you can take to lower your risk of this disease is to quit smoking, and if you don’t smoke, stay away altogether.

Heavy drinking is linked to pancreas inflammation, a contributing element for this malignancy, so reducing or abstaining from drinks may assist lower your chance.

Controlling your weight or losing weight may also help decrease your susceptibility. Individuals with obesity are 20% more likely to develop this disease. This malignancy also is more frequent in people with diabetes, and weight loss can also reduce the risk of type 2 diabetes.

In spite of pancreatic cancer’s grim outlook, there is still hope.

“We are doing better with treatments and more recent combination chemotherapy. There are developing targeted therapies that already are making an impact,” remarked a expert.

For many individuals, however, awareness about this rare but {dev